Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal of Translational Medicine

Fig. 2

From: C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

Fig. 2

C14orf166 upregulation in bladder cancer tissues. a Quantitative RT-PCR determination of C14orf166 expression in bladder cancer tissues and adjacent bladder tissues from six patients. Transcription levels were normalized to GAPDH expression. b Western blot analysis of C14orf166 expression in bladder cancer tissues and adjacent bladder tissues. α-Tubulin was used as the loading control. c IHC determination of C14orf166 expression in different patients with different clinical stages of disease according to T classification (magnification: ×200, ×400)

Back to article page